Growth Metrics

Nautilus Biotechnology (NAUT) Cash from Financing Activities (2020 - 2026)

Nautilus Biotechnology has reported Cash from Financing Activities over the past 7 years, most recently at $1.1 million for Q1 2026.

  • Quarterly results put Cash from Financing Activities at $1.1 million for Q1 2026, up 6038.89% from a year ago — trailing twelve months through Mar 2026 was $1.3 million (up 41.88% YoY), and the annual figure for FY2025 was $214000.0, down 81.29%.
  • Cash from Financing Activities reached $1.1 million in Q1 2026 per NAUT's latest filing, up from $101000.0 in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $1.1 million in Q1 2026 and bottomed at $1000.0 in Q1 2023.
  • Median Cash from Financing Activities over the past 5 years was $137500.0 (2022), compared with a mean of $212062.5.
  • The largest annual shift saw Cash from Financing Activities tumbled 99.94% in 2022 before it soared 24400.0% in 2024.
  • Over 5 years, Cash from Financing Activities stood at $135000.0 in 2022, then skyrocketed by 87.41% to $253000.0 in 2023, then surged by 73.91% to $440000.0 in 2024, then tumbled by 77.05% to $101000.0 in 2025, then surged by 994.06% to $1.1 million in 2026.
  • Business Quant data shows Cash from Financing Activities for NAUT at $1.1 million in Q1 2026, $101000.0 in Q4 2025, and $95000.0 in Q2 2025.